Clinical Trials Browser

Phase 1/2 × Non-Muscle Invasive Bladder Neoplasms × Mitozytrex × Clear all

NCT06704191 2026-03-30

In-home Intravesical Chemotherapy for the Treatment of Bladder Cancer, INVITE Trial

Phase 1/2 Recruiting

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms